The In-Practice Prescribing Pattern for Antibiotics in the Management of Diabetic Foot: Needs Much More to be done!

被引:2
作者
Ali, N. [1 ]
Rehman, S. [1 ]
Imran, M. [1 ]
Hussian, I [1 ]
Shehbaz, N. [1 ]
Jamshed, H. [1 ]
Hayat, A. [2 ]
Khan, S. [3 ]
Anwar, M. J. [4 ]
机构
[1] Univ Malakand, Dept Pharm, Chakdara, Pakistan
[2] Govt Lady Reading Hosp LRH, Postgrad Med Inst, Peshawar, Pakistan
[3] Hayatabad Med Complex HMC Hosp, Peshawar, Pakistan
[4] Khyber Teaching Hosp KTH, Peshawar, Pakistan
关键词
Antibiotic; ceftriaxone and co-amoxiclav; diabetes mellitus; diabetic foot; mean age;
D O I
10.4103/0975-1483.59331
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More than 850 patients' medication history forms were evaluated, retrospectively, for possible irrationalities in the prescribing pattern of antibiotics for management of hospitalized diabetic foot cases. Primary anti-diabetic therapy included insulin, oral anti-diabetic, or combination of both. Supportive therapy included antibiotics for diabetic foot cases and other physical measures like routine wound dressings and washing. Antibiotic therapy was analyzed based on the reported medical literature. It was deduced that in addition to other supportive measures advised for the management of diabetic foot, the antibiotic therapy for management of diabetic foot (n=410) was in the order of ceftriaxone (83.3%) > co-amoxiclav (36.66%) > clindamycin and ciprofloxacin (26.66%) > cefuroxime and levofloxacin (10.0%) > clarithromycin and cefoperazone / sulbactam, cephradine and fusidic acid (6.6%) > cefotaxime sodium and oxytetracyclin (3.33%). Placing ceftriaxone as a first choice (83.3%) in the antibiotic therapy carries no logic as ceftriaxone has low activity against reported higher incidence (85 %) of gram-positive organisms such as Staphylococcus aureus and streptococcus species. Prescribing irrationality of antibiotics is a global phenomenon that shall be addressed right from the medical/pharmacy schools levels.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 19 条
[1]  
Barar FS, 2004, ESSENTIALS PHARMACOT, P344
[2]  
Cantrill JA, 2006, CLIN PHARMACOL THER, p[666, 670, 675]
[3]   Review article: diabetes, genetics and ethnicity [J].
Carulli, L ;
Rondinella, S ;
Lombardini, S ;
Canedi, I ;
Loria, P ;
Carulli, N .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 :16-19
[4]   Barriers to providing diabetes care in community health centers [J].
Chin, MH ;
Cook, S ;
Jin, L ;
Drum, ML ;
Harrison, JF ;
Koppert, J ;
Thiel, F ;
Harrand, AG ;
Schaefer, CT ;
Takashima, HT ;
Chiu, SC .
DIABETES CARE, 2001, 24 (02) :268-274
[5]  
Chowdhury Q., 1990, P INT CONS RAT DRUG, P26
[6]  
Day Caroline, 2007, Diab Vasc Dis Res, V4, P32, DOI 10.3132/dvdr.2007.003
[7]  
Dolence K., 2004, J MED CHEM, V47, P4113
[8]  
FOLLI HL, 1987, PEDIATRICS, V79, P718
[9]   Use, of chart and record reviews to detect medication errors in a state psychiatric hospital [J].
Grasso, BC ;
Genest, R ;
Jordan, CW ;
Bates, DW .
PSYCHIATRIC SERVICES, 2003, 54 (05) :677-681
[10]  
HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1